23 Volkov, I
Date: January 29, 2026 Source: BMJ Group Summary: Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain
She said those treating autoimmune diseases dont want to turn to GLP-1 drugs without a better understanding of how and why autoimmune patients may benefit from them
Beyond clinical trial data, many patients report feeling tired or experiencing low energy when starting or adjusting doses of these medications
For weight management, lack of at least 5% weight loss by 12 weeks at the maintenance dose warrants discussion about alternative strategies or dose optimization
Recent findings have indicated that levels of the atypical methyltransferase METTL1 are elevated in cancer cells, thereby promoting glutamine synthase (GLUL) expression in an m6A-dependent manner, which in turn facilitates cancer cell proliferation [44]